The Trilogy ventilator is a portable life-support device used to help people breathe when their lungs or respiratory muscles can’t do the job on their own. Made by Philips Respironics, it’s one of the two most commonly used home ventilators in the United States and serves patients ranging from children weighing at least 11 pounds to adults. It supports both non-invasive ventilation (through a face mask) and invasive ventilation (through a tracheostomy tube), making it versatile enough for use at home, in long-term care facilities, and in hospital settings.
Conditions That Require a Trilogy Ventilator
The Trilogy is most often prescribed for people with progressive neuromuscular diseases that weaken the muscles involved in breathing. This includes conditions like ALS (amyotrophic lateral sclerosis), muscular dystrophy, myasthenia gravis, and post-polio syndrome. For these patients, the ventilator may be needed continuously, sometimes 24 hours a day, because their respiratory muscles can no longer sustain adequate breathing on their own. In these cases, the device is classified as life support: if it stops working, the patient could die.
Beyond neuromuscular disease, the Trilogy is used for chronic respiratory failure caused by COPD, obesity hypoventilation syndrome (where excess weight restricts breathing, especially during sleep), and thoracic restrictive diseases that limit how much the chest wall can expand. Some patients use it only at night to support breathing during sleep, while others depend on it around the clock. The specific schedule depends on how much respiratory function a person has left.
How It Delivers Breathing Support
Unlike a simple CPAP machine that pushes air at one constant pressure, the Trilogy can cycle between different pressure levels and switch between several ventilation modes depending on what a patient needs. It can deliver volume-controlled breaths (pushing a set amount of air with each cycle), pressure-controlled breaths (maintaining a set pressure), or a combination of both. One notable mode, called AVAPS (Average Volume Assured Pressure Support), automatically adjusts pressure breath by breath to make sure the patient receives a target volume of air, even as their condition or body position changes.
The device also offers a spontaneous/timed mode, which lets patients breathe on their own when they can but kicks in with a machine-delivered breath if they pause too long. This flexibility is part of what distinguishes the Trilogy from simpler bilevel (BiPAP) machines. It can act as a full life-support ventilator for someone who cannot breathe independently, or it can gently assist someone who still has partial respiratory function.
Non-Invasive and Invasive Interfaces
The Trilogy works with multiple types of patient interfaces. For non-invasive ventilation, it connects to a face mask, either a nasal mask or a full-face mask that covers the nose and mouth. For invasive ventilation, it connects directly to a tracheostomy tube or, in acute settings, an endotracheal tube placed through the airway.
The device also supports different circuit configurations: passive circuits (simpler setups with a single tube and an exhaust port), active circuits that use a separate valve to control exhalation, and dual-limb circuits with separate tubes for inhaled and exhaled air. The choice of circuit depends on the clinical situation and how precisely exhaled air needs to be managed.
Home Use and Portability
The Trilogy was designed specifically to move with the patient rather than tethering them to a hospital bed. The newer Trilogy Evo weighs about 11.5 pounds and runs on a combination of internal and detachable batteries that provide up to 15 hours of operation, a significant improvement over the older Trilogy 100 and 200 models, which offered roughly 6 hours of battery life. That battery capacity means patients can leave the house, travel in a wheelchair, or move between rooms without being plugged into a wall outlet.
Setting up home ventilation typically involves a respiratory therapist from a durable medical equipment (DME) company who configures the device, adjusts the settings to the patient’s prescription, and trains the patient or caregiver on daily use. Some patients are started on the ventilator during a hospital stay or in a sleep lab, while others begin the process entirely at home. Once running, the device tracks data points like tidal volume (the amount of air per breath), leak rates, and the percentage of breaths the patient initiates on their own. Clinicians can review this data remotely through cloud-based monitoring software, allowing them to adjust settings without requiring an office visit.
Built-In Safety Monitoring
Because the Trilogy can function as life support, it includes alarms designed to catch problems in real time. These include alerts for high or low tidal volume (meaning the patient is getting too much or too little air per breath), excessive mask leak, and inaccurate oxygen delivery. The device monitors pressure, volume, and airflow continuously. If debris blocks the internal flow sensor or a software error occurs, these readings can become unreliable, which is why routine maintenance and software updates matter.
Recall History
In June 2021, Philips Respironics recalled the Trilogy 100 and Trilogy 200 models manufactured between 2009 and April 2021. The issue involved a sound-dampening foam inside the devices that could break down over time, potentially releasing small particles or chemicals into the airflow. Hot and humid conditions accelerated the breakdown, and using ozone-based cleaning devices made it worse. In April 2024, a federal court entered a consent decree requiring Philips to provide affected patients with a new or repaired device, or in some cases a partial refund. If you have an older Trilogy 100 or 200, checking the FDA’s recall page or contacting your DME provider will confirm whether your specific unit is affected and what remediation options are available.
Who It’s Designed For
The Trilogy is cleared for pediatric through adult patients weighing at least 5 kilograms (11 pounds). In practice, it’s used for a wide range of people: children with congenital neuromuscular conditions, adults with progressive diseases like ALS, older adults with severe COPD or obesity-related breathing problems, and patients transitioning from hospital ventilators to long-term home care. It’s also used in long-term care facilities and sub-acute rehab settings where patients need ongoing ventilatory support but no longer require intensive care.
The common thread across all these uses is that the patient’s own breathing is insufficient, either because the muscles are too weak, the lungs are too damaged, or the chest wall is too restricted, and the Trilogy fills the gap by delivering air at the right pressure, volume, and timing to keep oxygen levels safe.